Eden Research plc
LSE : EDE

May 17, 2011 02:00 ET

Completeness of dossier decision

                                                                                  GB0001646941/GBP/PLUS-exn
                                                                                                17 May 2011

                                                     
                                             EDEN RESEARCH PLC
                                           ("Eden" or "Company")

                                     Completeness of dossier decision

Eden  Research  plc,  a  leading UK agrochemical development company, today  announces  that  the  European
Commission  has  officially  communicated to the Company that it has passed  a  resolution  confirming  the
completeness of the dossiers for the three active substances submitted by Eden, under Directive 91/414/EEC.

As  a  result, Eden has now started the process of submitting EU zonal applications for provisional product
approvals which will enable the sales of products using Eden's active substances and technologies.

The  three  active  substance dossiers submitted by Eden are now with the European  Food  Safety  Authority
("EFSA") for their review. Once EFSA have completed their review process, the European Commission will vote
on  the  inclusion  of  Eden's active substances onto Annex I. Annex I is the  list  of  active  substances
approved for use in pesticidal products.

All  three  of Eden's active substances have been submitted to EFSA with Chemicals Regulation Directorate's
recommendation for Annex I inclusion.

Clive Newitt, Managing Director of Eden Research, said:

"This is another important hurdle which has been passed by Eden in this on-going regulatory process.

Eden and its commercial partners can now concentrate on gaining national and zonal product approvals whilst
the  Annex  I  process  continues, in order to expedite sales of products  using  Eden's  unique,  patented
encapsulation technology."


The Directors of Eden Research PLC are responsible for the contents of this announcement.


Enquiries:

Eden Research plc                                                                  01993 862761
Clive Newitt, Managing Director

St Helens Capital Partners LLP                                                     020 7368 6959
Mark Anwyl



Notes:

Eden's  strategy  is  focused  on the development and commercialisation of its terpene-based  encapsulation
technology for agricultural and non-agricultural uses through appropriate regional or global partnerships.

Terpenes  are natural compounds which function as defence mechanisms in many plant groups and are  released
in response to infection, attack by pests, stress or mechanical injury. Terpenes are already widely used in
the food flavouring, cosmetic and pharmaceutical industries.

Historically, terpenes have had limited commercial use in the agrochemical sector due to their  volatility,
phytotoxicity  and poor solubility. Eden's platform encapsulation technology provides the  unique,  natural
solution to these problems and enables terpenes to be used as effective, low-risk agrochemicals.

For more information, please visit www.edenresearch.com

Contact Information

  • Eden Research plc